• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Stifel Financial Corporation

    3/20/25 4:30:15 PM ET
    $SF
    Investment Bankers/Brokers/Service
    Finance
    Get the next $SF alert in real time by email
    8-K
    STIFEL FINANCIAL CORP false 0000720672 0000720672 2025-03-14 2025-03-14 0000720672 us-gaap:CommonStockMember 2025-03-14 2025-03-14 0000720672 us-gaap:SeriesBPreferredStockMember 2025-03-14 2025-03-14 0000720672 us-gaap:SeriesCPreferredStockMember 2025-03-14 2025-03-14 0000720672 us-gaap:SeriesDPreferredStockMember 2025-03-14 2025-03-14 0000720672 sfb:M5.20SeniorNotesDue2047Member 2025-03-14 2025-03-14

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): March 14, 2025

     

     

    STIFEL FINANCIAL CORP.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-09305   43-1273600

    (State of

    incorporation)

     

    (Commission

    File Number)

      (IRS Employer
    Identification No.)

    501 N. Broadway, St. Louis, Missouri 63102-2188

    (Address of principal executive offices and zip code)

    (314) 342-2000

    (Registrant’s telephone number, including area code)

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class

     

    Trading
    Symbol(s)

     

    Name of Each Exchange
    on Which Registered

    Common Stock, $0.15 par value per share   SF   New York Stock Exchange
    Depository Shares, each representing 1/1,000th interest in a share of 6.25% Non-Cumulative Preferred Stock, Series B   SF-PB   New York Stock Exchange
    Depository Shares, each representing 1/1,000th interest in a share of 6.125% Non-Cumulative Preferred Stock, Series C   SF-PC   New York Stock Exchange
    Depository Shares, each representing 1/1,000th interest in a share of 4.50% Non-Cumulative Preferred Stock, Series D   SF-PD   New York Stock Exchange
    5.20% Senior Notes due 2047   SFB   New York Stock Exchange

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 4.01

    Changes in Registrant’s Certifying Accountant.

    On March 14, 2025, upon the completion of a comprehensive selection process, the Audit Committee of the Board of Directors of Stifel Financial Corp. (the “Company”) approved (1) the dismissal of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm, effective immediately, and (2) the appointment of KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, and related interim periods. The Company informed EY of their dismissal on March 14, 2025.

    The reports of EY on the consolidated financial statements of the Company as of and for the fiscal years ended December 31, 2024 and 2023 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles.

    In connection with the audits of the Company’s consolidated financial statements for each of the fiscal years ended December 31, 2024 and 2023, and in the subsequent interim period through March 14, 2025, there were no disagreements between the Company and EY on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedures which, if not resolved to the satisfaction of EY would have caused EY to make reference to the matter in their report.

    The Company has requested EY to furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made herein. A copy of such letter dated March 20, 2025, is filed as Exhibit 16.1 to this Current Report on Form 8-K.

    During the fiscal years ended December 31, 2024 and 2023 and during the subsequent interim period through March 14, 2025, neither the Company nor anyone acting on its behalf consulted with KPMG regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements and neither a written report nor oral advice was provided to the Company that KPMG concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a “disagreement” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a “reportable event” (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions).

     

    Item 9.01

    Financial Statements and Exhibits.

     

    (d)

    Exhibits.

     

    Exhibit
    Number

      

    Description

    16.1    Letter from Ernst & Young LLP dated March 20, 2025.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    2


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

     

     

     

         

    STIFEL FINANCIAL CORP.

    (Registrant)

    Date: March 20, 2025     By:  

    /s/ James M. Marischen

        Name:   James M. Marischen
        Title:   Chief Financial Officer

     

    3

    Get the next $SF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SF

    DatePrice TargetRatingAnalyst
    4/24/2025$108.00Peer Perform → Outperform
    Wolfe Research
    12/10/2024$120.00Neutral
    Analyst
    9/12/2024$101.00Overweight
    Wells Fargo
    7/22/2024Outperform → Peer Perform
    Wolfe Research
    7/8/2024$94.00 → $89.00Buy → Hold
    TD Cowen
    1/4/2024$83.00Outperform
    TD Cowen
    11/22/2022$66.00Neutral
    UBS
    10/12/2022$60.00Neutral
    Citigroup
    More analyst ratings